SELECT PUBLICATIONS
Jain R. Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy. Science 2005;307:58-62. Abstract
Jain R. Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy. Nat Med 2001;7(9):987-9. Abstract
Ryan D et al. Phase I/II study of preoperative oxaliplatin, fluorouracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: Cancer and Leukemia Group B 89901. J Clin Oncol 2006;24(16):2557-62. Abstract
Willett C et al. Complete pathological response to bevacizumab and chemoradiation in advanced rectal cancer. Nat Clin Pract Oncol, England 2007;4(5):316-21. Abstract
Willett C et al. Combined vascular endothelial growth factor-targeted therapy and radiotherapy for rectal cancer: Theory and clinical practice. Semin Oncol 2006;33(5 Suppl 10):35-40. Abstract
Willett C et al. Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. Nat Med 2004;10(2):145-7. Abstract
